Skip to main content
. 2015 Nov 2;16(3):1021–1030. doi: 10.1111/ajt.13487

Table 4.

HLA antibody analysis of patient 2

C1q Day 674 Day 740 Day 814 Day 1062
B37 + 4475 4075 2809 ND
B8* 4129 3448 2523 3402
B50* 1491 1307 ND 8352
B49 1194 1005 ND 5774
DR7* 8712 6607 5819 11119
DR53 + 7108 5497 5165 10471
DP3 + 6434 4661 4661 9725
DR4 * + 5988 9055 8942 11835
DP9 + 5764 4528 4463 7306
DP20 + 5729 3930 4248 6896
DP6 + 5587 4455 4386 9566
DQ2 * + 5261 3793 2917 3524
DP14 4975 3597 4001 8258
DR9 4401 2960 2949 4829
DR12 + 4061 2046 2631 1070
DR52 + 3783 2560 2505 ND
DP17 + 3674 2756 2986 10029
DP5 2121 1565 1523 9277
DP11 + 1993 1437 1348 9099
DP1 1956 1443 1390 9372
DP19 + 1589 1205 1139 10847
*

Donor‐specific antibody.

MFI values and C1q positivity for patient 2 on days 674, 740, 814, and 1062 after hepatocyte transplantation. Day 1062 is 111 days after liver transplantation. C1q reactivity was normalized to background, and MFI values >1000 were considered positive. +, positive; MFI, mean fluorescence intensity; NA, not available; ND, below threshold limit of 1000 MFI.